Synergistic mesenchymal and neural stem cell therapy: Advancing neurorestoration in cerebral infarction
Authors:
- Noura A A EbrahimNENoura A A Ebrahim
- Moamen O OthmanMOMoamen O Othman
- Neveen S TahounNTNeveen S Tahoun
- Thoraya A FarghalyTFThoraya A Farghaly
- Soliman M A SolimanSSSoliman M A Soliman
Open Access
- 26 February 2026
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Stem Cells
- Vol. 18 (2)
Abstract
Recent clinical and translational studies have increasingly highlighted the promise of combined stem cell strategies for neurorestoration following ischemic stroke. In this correspondence, we reflect on the recent trial by Yang et al , which reported that co-transplantation of mesenchymal stem cells (MSCs) and neural stem cells (NSCs) yielded significantly greater functional recovery in patients with acute cerebral infarction, as evidenced by improvements in both Barthel Index and National Institutes of Health Stroke Scale scores. Notably, this dual-cell intervention was accompanied by robust elevation of angiogenic and neurotrophic mediators, particularly vascular endothelial growth factor and basic fibroblast growth factor, suggesting a biologically plausible mechanism for the observed clinical benefit. MSCs contribute through trophic support, immunomodulatory effects, and promotion of vascular regeneration, whereas NSCs primarily facilitate neuronal replacement and reorganization of neural circuits. Together, these mechanisms offer a comprehensive, multitargeted approach to address the multifactorial nature of stroke pathology. Building on this pivotal work, we call for mechanistic studies and multicenter randomized clinical trials to refine cell dosing, timing, and bioengineering strategies, paving the way for the clinical integration of MSC/NSC co-therapy as a next-generation regenerative treatment for stroke.Keywords
This publication has 8 references indexed in Scilit:
- Combined mesenchymal and neural stem cell therapy enhances neurological recovery in cerebral infarctionWorld Journal of Stem Cells, 2025
- The Role of Stem Cells as Therapeutics for Ischaemic StrokeCells, 2024
- Mesenchymal Stem Cells: Therapeutic Mechanisms for StrokeInternational Journal of Molecular Sciences, 2022
- Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and ChallengesFrontiers in Cellular Neuroscience, 2021
- Neural stem cell transplantation therapy for brain ischemic stroke: Review and perspectivesWorld Journal of Stem Cells, 2019
- Transplantation of bFGF-expressing neural stem cells promotes cell migration and functional recovery in rat brain after transient ischemic strokeOncotarget, 2017
- Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic strokeWorld Journal of Stem Cells, 2017
- Combination Cell Therapy with Mesenchymal Stem Cells and Neural Stem Cells for Brain Stroke in RatsInternational Journal of Stem Cells, 2015